chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever; Tired; Aches; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 22Apr2021 at 11:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included iron (MANUFACTURER UNKNOWN) and cyanocobalamin (VITAMIN B-12); both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Apr2021 at 21:00, the patient experienced aches 12 hours later and then headache. On 23Apr2021 after 24 hours, the patient experienced fever and tired as well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events aches, headache, fever and tired were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache; This is a spontaneous report received from a contactable reporter. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache".  Additional Information: Consumer stated that the reason he was calling because he took my Pfizer first shot on (26Feb2021) and second shot on 19Mar2021 and had taken this we going to be ringing in ears last 35 (not clarified) and after the first shot he ended up getting headache not thinking too much about it but very highly and after his second shot it even got worse and already been to the doctor to see if he found out anybody having any problem with Covid shots concerning the ringing in ears. Consumer was informed about Pfizer. And in response to it further stated that his hearing was not very good, so he was stressing right now.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Severe Pain in left shoulder and Arm.  Beginning about an hour after the shot. Increasing to include entire left arm.  There is limited movement in the arm without severe pain. There has been no significant decrease in the months since vaccination.
Shortness of breath started on 4/24, became severe on 4/26 so patient came to Emergency Department. Pt also with chest tightness when lying down. Found to have saddle PE. She was admitted to ICU, started on a heparin drip, and is being considered for possible EKOS (catheter-directed ultrasound guided thrombolysis) depending on her echo findings (pending)
Patient states she had a fever within 3 days, her eyes were red and swollen, she got bumps around her face and her lips were dry.  She also states she saw and eye doctor as well as a dermatologist.
Approximately 2 days after vaccine, pt experienced mid and upper back and neck pain and stiffness. Today he played basketball and symptoms worsened. He is concerned that his symptoms are a result of the vaccination.
PATIENT'S MOTHER REFERS THAT ABOUT 2 TO 3 HOURS AFTER VACCINATION THE BOY WAS TAKING A BATH AND THE MOTHER FOUND HIM CYANOTIC AND LOST CONSCIOUSNESS. SHE TOOK HIM TO EMERGENCY ROOM.
3:10pm: vaccine given 3:20pm: patient asked for a soda to drink 3:25pm: I went to tell the patient their wait time was up and they could leave, and that is when he told me his throat was "scratch" and that is why he got the soda to drink.  I had him check his blood pressure with our automated booth out front and it was 166/99 (which is high for him he reported) 3:30pm: He was still complaining of scratchy throat and did not want Epi pen, I gave him 25mg of Benadryl Liquid 3:35pm: He was nervous that his throat was still scratchy, so we called EMS to evaluate 3:50pm: Patient went with EMS to hospital to be evaluated just to be on the safe side
mild headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (mild headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (mild headache). At the time of the report, HEADACHE (mild headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications were provided by the reporter. No Treatment History was provided by the reporter.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Non significant follow up is added
Severe chills; fever; body ache; diarrhea; fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Mar2021 18:00 (Lot number: CP7534) at the age of 40 years as dose 1, single and administered in arm left, administration date 07Apr2021 15:00 (Lot number: EW0153) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergies: Tree fruits" (unspecified if ongoing); "Allergies: nuts" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "Severe chills"; PYREXIA (non-serious), outcome "unknown", described as "fever"; PAIN (non-serious), outcome "unknown", described as "body ache"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; FATIGUE (non-serious), outcome "unknown", described as "fatigue".  Additional Information: patient experienced severe chills, fever, body ache, diarrhea and fatigue from 14:00 on day 2 which was 27 hrs after the booster shot. Felt worse than the 2nd shot and much worse than first shot. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive other medications in two weeks of vaccinations. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, since the vaccination.  No follow-up attempts are possible. No further information is expected.
Patient fainted after immediately getting both vaccines. Had patient sit in chair for 1 hour and monitored. Gave patient food and water.
Severe chillinf, fever over 102, loss of appetite, severe fatigue, and sever brain fog
Expiration date in the vaccination information system was 5/31/2022, but the beyond use date was 3/17/2022.
Mother called stating the daughter had received the vaccine on the 19th and late last night (the 21st) hives appeared - has taken Benadryl to deal with hives
Information has been received from a consumer concerning a 5 year old male patient (currently 7 years old) with no pertinent medical history and no known drug reactions or allergies, who on 13-NOV-2008 was vaccinated with a dose of MMR II (dose and route not reported) and lot # 658340/1011X. There was no concomitant medication. The consumer reported that when given the MMR II shot, on 13-NOV-2008 the patient experienced anaphylactic shock and dermatitis; he had a rash all over his body for about a year and was hospitalized (date not reported). Treatment for the adverse event included EPIPEN. Laboratory diagnostics studies were not performed. At the time of the report, on an unspecified date, the patient recovered from dermatitis and anaphylactic shock and it was also reported that the "rash lasted a year" (on 13-NOV-2009). Additional information has been requested.
Vaccine administered 10/31/13. Noticeable pain at time of injection. The night of the injection the pain at the site of the injection was extreme and excruciating. The following day it was dull pain. I took oral NSAID's. Pain has remained and varies from dull to extreme. By 11/12/13 shoulder completely frozen and extreme pain. Dr. prescribed antibiotics and more NSAID's.
moderate headache starting after 5 hours lasting 9 hours. Sore neck starting after 7 hours subsiding over 20 hours. swollen axillary lymph nodes starting 3 hours after lasting over 24+ hours. Sore arm 15 minutes after injection, increasing in severity before decreasing over 24+ hours. Sore injection site immediately lasting 24+ hours. Fatigue starting after 1 hour lasting 24 hours. No NSAIDs taken.
Flu like, light-headed, chills and severe shivers all night, fever and sweats.  Was OK in AM.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment was given for patient. It was reported that the vaccines were stored in freezer, were taken out one to two vials and were placed in fridge each day as needed.
This spontaneous report was received from a healthcare worker refers to a patient of unknown gender and age. Information regarding the patient's medical history, concurrent condition, drug reactions/allergies and concomitant medications were not provided. On 27-SEP-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (lot # M029599, expiry date: 10-DEC-2017). A data logger was involved. Healthcare worker reported that the vaccine underwent temperature excursion at 19.5F for 23 hours. They stated that the vaccine was previously exposed at 8.5F for 4 hours and 15 minutes. No adverse effect was reported. This is one of the four reports received from the same reporter. Additional information has been requested.
Patient contracted chickenpox and was diagnosed 5/4/08.  Patient presented with areas on torso, scalp and palms of hands with itching.  Areas papulovesicular with areas of crusting.
After being injected with the last of 3 Hepatitis A and B vaccine I presents with 27 side effects that according to the information I received, only 1% of the population responds with. That's me and I'm still dealing with the side effects in 8 systems - Musculoskeletal, Psychological, GI, Respiratory, Occular, Metabolic, Cardio., Dermo. The symptoms are so varied that none of the specialists I went to could tie it into their specialty. It wasn't until I did deeper research and found that ALL my side effects were listed under the 1% effected category. Disgusting that my hepatologist didn't provide me with that information before I agreed to the vaccinations.
Heart Rate fluctuations (64-110 bpm); Chills; abdominal cramping; Extreme diarrhea; Weakness; Nausea; This is a spontaneous report from a contactable Heath care professional, the Nurse. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EN6208), via an unspecified route of administration on Right Arm on 16Mar2021 at 17:15 hours (at the age of 51-years-old and the patient was not pregnant at the time of vaccination) as a single dose for COVID-19 immunization. Medical history included Seasonal Allergies and No other biomedical health issues were reported. Weight 119 lbs, small body frame. Past drug history have not been provided. Concomitant medications included Xzal, Vit B complex, Vit D, Vit C taken within two weeks prior to vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccine within four weeks. Since the vaccination, patient has not been tested for COVID-19. On 16Mar2021 at 21:15 hours, patient experienced Sudden Nausea, Abdominal cramps and Extreme Diarrhea with complete emptying (similar to a colonoscopy preparation) and also Chills, without fever, Weakness, and Heart Rate fluctuations with 64-110 beats per minute. The patient did not receive any treatment for adverse events. The clinical outcome of the all events were recovering. No follow-up attempts are needed. No further information is expected.
Received the vaccine being pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine being pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine being pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine being pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was reported. No concomitant medication was reported.  No lab tests was performed. It was reported that consent for follow up was denied.   Reporter did not allow further contact
About 10 minutes after vaccine I was extremely hot, dizzy, disoriented. My blood pressure was 30 points higher than usual and 15 minutes after the first episode, I had another episode.
Pt recvd 2nd dose of vax on 14MAY92 & approx 17MAY devel prutitic rash; seen by MD who dx herpes zoster;
MOC reports taking pt to ER w/swollen leg; treated for cellulitis on ATB;
This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer reporting for herself. This 81-year-old female patient received PREVNAR 13 via an unspecified route of administration, in Jun2016 at 0.5 ml single for immunization. Relevant medical history  was not reported. Concomitant medications were none. On 22Jun2016, the patient experienced red arm and sore. No treatment was required, but the patient was hospitalized (unspecified date in 2016). The outcome of the events was recovered on an unspecified date in 2016. Follow-up (14Sep2016):  New information received from the same contactable consumer includes: additional event (sore), onset date, seriousness (hospitalization), outcome, info on concomitant medications.
Right arm pain, redness, swelling, and itching with heat to touch; Headache; Muscle aches; Fatigue; Chills and Fever
Tdap administered 8/22/11. Localized induration & erythema began 8/23/11, induration 6 cm by 8/24/11. On 8/24/11 & 8/25/11, low grade (>100 degrees) fever, chills, & generalized achiness, resolved by 8/26. On 8/26, 5.5 cm localized induration persists.
Pain, erythema and swelling of L deltoid area about 24 hrs after vaccine administration in that area.  12.5 x 12.5 cm on 1/21/06.
muscle aches,   night fevers , pain in shot site  head ache   , fuzzy memory  ,  blurry vison  ,loss sense of smell     skin is all broke out with white heads .
Vaccines given 6/23/14. Developed redness and swelling at site (lt arm) that night. Tenderness on 6/24 and saw MD 6/25. Rx for KEFLEX 500mg/5ml - 5ml tid x 7d.
Within several days of vacine developed an irregular heartbeat. Went to my doctor on March 11th and was referred to a cardiologist. First appointment with cardiologist showed irregular heart beat and made appointment for further tests. On March 28th fitted with a moniter  for 3 days. Returned to cardiologist on April 1st for further test and told I was in A-Fib. PLaced on blood thinner and beta blocker. After 2 weeks no change so scheduled cardioversion for following week. Cardioversion was successful but still on medication.
Pt recv vax on 6/18/97; on 6/22/97 pt exp erythema multiforme- prominent blotches all over body.
The client tested positive for COVID-19 on 3/8/21 with symptoms beginning on 3/6/21.
This is a non-serious spontaneous case, initially received from other health professional on 12-Feb-2018, concerning a patient of an unspecified age and gender. On an unknown date, FLUCELVAX vaccine was kept in the refrigerator where temperature reached a max temperature of 53.2 F and was out of range for 5 hours and 57 minutes. It was reported that excursion occurred on 15-Jan-2018. On 20-Jan-2018, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 195250, expiry date: 30-Jun-2018) which underwent temperature excursion. It was reported that, the patient had no adverse events after the vaccination. Follow up received on 28-Feb-2018: The vaccine details (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid and indication: influenza prophylaxis) were updated. It was confirmed that, vaccine was administered on 20-Jan-2018. The narrative was amended accordingly.
Admitted to hospital for Cough, SOB, asthma exacerbation, elevated BNP, hypokalemia
Myocarditis - symptoms appeared 2 days following the vaccine.  Hospitalized with elevated troponin.  Started on oral steroids with improvement in labs and symptoms after 24 hrs.
started vomiting at 1:30 and I felt really dizzy and confused. My roommate found me on the floor passed out. I am not sure how long I was passed out. I woke up and I was talking gibberish. I was aware that nothing I said was making sense. I went to bed and slept almost 24 hours. I woke up feeling wiped out but I wasn't confused and I was talking normal again. Right arm hurt and is numb. ( right side of my body typically is kind of numb but the right arm seemed more so numb after the vaccine)
shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were not reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow up received and contains no new information.
Pt stated almost immedicately (same day) he became very fatigued. No fever, but lethargic. It lasted for 3 days for him.
Administration to a child under 4 years of age (Medication Error, Medication Error) (Med Error) - not reported  A report was received from a health care professional on 25 November 2003, concerning a 2 year old female vaccinee who advertently received Fluvirin on 21 November 2003. On 21 November 2003 the vacinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 1, 11 March 2004: Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow-up pending, all information received.
Within a couple of minutes of vaccination, I experienced shortness of breath, rapid heart rate, and disorientation.  I remained under observation for one hour, at which point I was able to drive home.  The symptoms decreased but remained until late that night.  On Friday evening, January 15, I developed an ear infection in both ears, a large dark bruise approximately the size of my hand behind my left knee, and the worst HSV outbreak of my lifetime.  The bruise dissipated after approximately one week.  I have had recurrent HSV outbreaks almost continuously since that time.  I still have the ear infection.  I called my doctor twice to request antibiotics for my ears, but she thought the infection would clear up without them.  After 5.5 weeks I called a third time and cefdinir 300mg twice daily antibiotic was prescribed for 10 days.  The ear infection remained after completion of the antibiotic course.  I began a new course of the same medicine without a break in treatment and am now on day 15 of antibiotics.  the infection is improving but not gone.
Chills, 'crackling' in lungs when supine, increased phlegm/clearing of throat.
Encephalitis post vaccination. Low grade fever, 1st chills, next extreme lethargy, then, unresponsive over 1-2 days.  4/17/07 Received medical records from hospital.  No D/C Summary available.  Records reveal patient experienced unresponsiveness after complained of HA & fever until on day of admission would only open eyes, no verbal response. Admitted 2/11-2/17/07 to ICU.  Temp on admit 100.8. Glasgow scale was 10.  Neuro consult revealed changes in mental status of unclear origin. FINAL DX: none provided.  Admit dx were viral meningitis vs encephalitis, toxic or drug effect or possible seizure. 5/25/07 Received D/C summary from hospital which reveals patient progressed well during hospital stay of 2/11-2/17/07. Final Dx: Post Vaccination encephalitis, resolving; acute renal failure, resolving.
Pt received a Pneumococcal PPSV23 (PNEUMOVAX) yesterday in left arm while he was in the clinic. Pt reports he began to experience pain and swelling in left arm a couple of hours after injection. Pt also reports slight nausea last night. Denies Arm above elbow remains swollen with increased warmth to area. No redness or rash noted. No redness around injection site noted. Dr. examined left arm. Pt was advised that he was having a local reaction to vaccine.
Acute onset of cough, SOB, facial swelling w/i 5 minutes of receiving vaccine. Received Epi-pen, Benadryl, O2 in office. Transferred to ED via ambulance.
Hives w/in 48 hours of vaccine. Hives on face/arm (L) knee.
-Headache starting 2h later, tx'd with acetaminophen.  -13h after shot, awoke with emesis, chills, arthralgias.           Seen at ED, constitutional and GI sx, no skin sx.  Given analgeics, reglan and benadryl.  Sx improved.  -2-3d after shot, had tingling with pressure on hands and feet for 2-3d, itchy on hands  -She traveled and had itch across all of body there, was seen in ED and given unspecified antihistamine and famotidine.  -Another ED visit for lip and oral swelling, treated  with Epi-pen injection as well as dexamethasone and famotidine.  -No further oral/airway involvement, but had discomfort swallowing for a few days, GI bloating, and has had variable loose BMs 2-3x/day for several weeks, continuing now.